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During the last three decades, the areas of inherited white matter (WM) disorders have expanded. Advances 
in magnetic resonance imaging (MRI) and genetics have led to increased detection of adult-onset WM dis-
orders. Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an adult-onset, invariably lethal, 
brain WM disorder with an autosomal dominant inheritance pattern.  The clinical symptoms are character-
ized by a constellation of features that progress to a devastating disease with multiple neurological impair-
ments. The neuropathological hallmarks of HDLS are demyelination and the presence of axonal spheroids. 
The overall aim of this study was to gather enough clinical cases, radiological images, cerebrospinal fluid 
(CSF) biomarkers and molecular genetic data to place HDLS in a nosographic context and define its 
relationship with other neurodegenerative disorders. 
We updated the original Swedish HDLS family and created a pedigree consisting of 166 individuals. Fifteen 
of those cases were affected with HDLS, including two new cases. The clinical course was different in the 
two recent cases, with a sub-acute and a more chronic variant, respectively. Familial clustering of HDLS is 
not always obvious and in the Mayo Clinic HDLS collection we found that all of our cases had been misdi-
agnosed with other more common neurological disorders. Using exome sequencing, we identified the colony 
stimulating factor 1 receptor (CSF1R) mutation in 14 Mayo Clinic HDLS families. MRIs of 15 of these 
CSF1R mutation carriers demonstrated asymmetric WM lesions (WML) with frontoparietal predominance. 
With diffusion weighted-, and diffusion tensor imaging (DTI/DWI) we defined three different stages of 
HDLS pathology, and detected a peripheral rim of restricted diffusion that had a centrifugal migration 
from the anterior ventricular horns. This might be pathognomonic for the original Swedish type of HDLS.
In conclusion, HDLS is a distinct disease entity and the combination of clinical features such as frontal 
lobe syndromes, pyramidal-, extrapyramidal-, parietal- and visual signs, as well as WML in a characteristic 
frontoparietal distribution gives diagnostic clues. To clarify the distinction between the unknown genetics 
of the original Swedish family and the CSF1R mutation carriers, we propose to use molecular classification 
of HDLS type 1 and type 2, respectively. Results from our studies indicate that HDLS is probably primar-
ily a neuroaxonal degeneration. Thus, elucidating the molecular mechanism of HDLS may provide novel 
insights into neurodegeneration.
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